剪接因子SRSF1调控T细胞稳态,其水平降低与系统性红斑狼疮淋巴细胞减少相关
本研究探讨SRSF1在SLE T细胞稳态中的作用。SLE患者T细胞SRSF1低水平与淋巴细胞减少相关;T细胞特异性Srsf1敲除小鼠出现T细胞淋巴细胞减少、凋亡增加及抗凋亡蛋白Bcl-xL表达降低。SLE患者中SRSF1低表达与T细胞Bcl-xL低水平相关,且Bcl-xL低水平与淋巴细胞减少相关;过表达SRSF1可挽救SLE患者T细胞存活。
要点
- SLE患者T细胞SRSF1低水平与淋巴细胞减少相关。
- T细胞Srsf1敲除小鼠出现T细胞淋巴细胞减少、凋亡增加及Bcl-xL降低。
- 过表达SRSF1可挽救SLE患者T细胞存活。
核心结论
- SRSF1调控T细胞稳态,其表达降低是导致系统性自身免疫中淋巴细胞减少的分子缺陷。
研究设计与样本
- 评估SLE患者T细胞SRSF1表达并与临床参数分析相关性,使用T细胞条件性Srsf1敲除小鼠及流式细胞术、定量PCR、免疫印迹和电转染过表达实验。
主要发现
- SLE患者T细胞低SRSF1水平与淋巴细胞减少相关。
- 小鼠T细胞选择性删除Srsf1导致T细胞淋巴细胞减少,伴凋亡增加和抗凋亡蛋白Bcl-xL表达降低。
- SLE患者T细胞SRSF1低表达与Bcl-xL低水平相关,Bcl-xL低水平与淋巴细胞减少相关。
- 过表达SRSF1可挽救SLE患者T细胞存活。
临床怎么用
- SRSF1及其下游Bcl-xL通路可能作为理解SLE淋巴细胞减少机制及潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lymphopenia is a frequent clinical manifestation and risk factor for infections in SLE, but the underlying mechanisms are not fully understood. We previously identified novel roles for the RNA-binding protein serine arginine-rich splicing factor 1 (SRSF1) in the control of genes involved in signalling and cytokine production in human T cells. SRSF1 is decreased in T cells from patients with SLE and associates with severe disease. Because SRSF1 controls the expression of apoptosis-related genes, we hypothesized that SRSF1 controls T cell homeostasis and, when reduced, leads to lymphopenia. METHODS: We evaluated SRSF1 expression in T cells from SLE patients by immunoblots and analysed its correlation with clinical parameters. T cell conditional Srsf1 knockout mice were used to evaluate lymphoid cells and apoptosis by flow cytometry. Quantitative PCR and immunoblots were used to assess Bcl-xL mRNA and protein expression. SRSF1 overexpression was performed by transient transfections by electroporation. RESULTS: We found that low SRSF1 levels correlated with lymphopenia in SLE patients. Selective deletion of Srsf1 in T cells in mice led to T cell lymphopenia, with increased apoptosis and decreased expression of the anti-apoptotic Bcl-xL. Lower SRSF1 expression correlated with low Bcl-xL levels in T cells and lower Bcl-xL levels associated with lymphopenia in SLE patients. Importantly, overexpression of SRSF1 rescued survival of T cells from patients with SLE. CONCLUSION: Our studies uncovered a previously unrecognized role for SRSF1 in the control of T cell homeostasis and its reduced expression as a molecular defect that contributes to lymphopenia in systemic autoimmunity.
引用
- Katsuyama T, Martin-Delgado IJ, Krishfield SM, et al. Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus. Rheumatology (Oxford). 2020. PMID: 32206811. doi:10.1093/rheumatology/keaa094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。